These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 26976379

  • 21. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
    Meier S, Weber R, Zbinden R, Ruef C, Hasse B.
    Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
    [Abstract] [Full Text] [Related]

  • 22. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
    Sethaphanich N, Santanirand P, Rattanasiri S, Techasaensiri C, Chaisavaneeyakorn S, Apiwattanakul N.
    Pediatr Int; 2016 May; 58(5):338-46. PubMed ID: 26513341
    [Abstract] [Full Text] [Related]

  • 23. Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela.
    Guzmán M, Salazar E, Cordero V, Castro A, Villanueva A, Rodulfo H, De Donato M.
    Biomedica; 2019 May 01; 39(s1):96-107. PubMed ID: 31529852
    [Abstract] [Full Text] [Related]

  • 24. FACTORS ASSOCIATED WITH EXTENDED SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI IN COMMUNITY-ACQUIRED URINARY TRACT INFECTION AT HOSPITAL EMERGENCY DEPARTMENT, BANGKOK, THAILAND.
    Savatmorigkorngul S, Poowarattanawiwit P, Sawanyawisuth K, Sittichanbuncha Y.
    Southeast Asian J Trop Med Public Health; 2016 Mar 01; 47(2):227-33. PubMed ID: 27244961
    [Abstract] [Full Text] [Related]

  • 25. Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community.
    Lee JC, Lee NY, Lee HC, Huang WH, Tsui KC, Chang CM, Lee CC, Chen PL, Wu CJ, Hsueh PR, Ko WC.
    J Microbiol Immunol Infect; 2012 Apr 01; 45(2):127-33. PubMed ID: 22041167
    [Abstract] [Full Text] [Related]

  • 26. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
    Angel Díaz M, Ramón Hernández J, Martínez-Martínez L, Rodríguez-Baño J, Pascual A, Grupo de Estudio de Infección Hospitalaria (GEIH).
    Enferm Infecc Microbiol Clin; 2009 Nov 01; 27(9):503-10. PubMed ID: 19329230
    [Abstract] [Full Text] [Related]

  • 27. Risk factors for community acquired pediatric urinary tract infection with extended-spectrum-β-lactamase Escherichia coli - A case-control study.
    Collingwood JD, Wang L, Aban IB, Yarbrough AH, Boppana SB, Dangle PP.
    J Pediatr Urol; 2023 Feb 01; 19(1):129.e1-129.e7. PubMed ID: 36344365
    [Abstract] [Full Text] [Related]

  • 28. Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case-control study.
    Søgaard M, Heide-Jørgensen U, Vandenbroucke JP, Schønheyder HC, Vandenbroucke-Grauls CMJE.
    Clin Microbiol Infect; 2017 Dec 01; 23(12):952-960. PubMed ID: 28377310
    [Abstract] [Full Text] [Related]

  • 29. Extended-spectrum β-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre.
    Jacmel L, Timsit S, Ferroni A, Auregan C, Angoulvant F, Chéron G.
    Acta Paediatr; 2017 Jan 01; 106(1):142-147. PubMed ID: 27542840
    [Abstract] [Full Text] [Related]

  • 30. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW, Trivedi T, Montgomery M, Petrovic DF, Yamaji R, Riley L.
    Ann Emerg Med; 2018 Oct 01; 72(4):449-456. PubMed ID: 29980462
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study.
    Esteve-Palau E, Solande G, Sánchez F, Sorlí L, Montero M, Güerri R, Villar J, Grau S, Horcajada JP.
    J Infect; 2015 Dec 01; 71(6):667-74. PubMed ID: 26380898
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Community-acquired urinary tract infections due to extended-spectrum β -lactamase-producing organisms in United Arab Emirates.
    Ranjan Dash N, Albataineh MT, Alhourani N, Khoudeir AM, Ghanim M, Wasim M, Mahmoud I.
    Travel Med Infect Dis; 2018 Dec 01; 22():46-50. PubMed ID: 29409967
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
    Lagree M, Bontemps S, Dessein R, Angoulvant F, Madhi F, Martinot A, Cohen R, Dubos F, GPIPGroupe de pathologie infectieuse pédiatrique (Paediatric Infectious Disease Group), France..
    Med Mal Infect; 2018 May 01; 48(3):193-201. PubMed ID: 29449049
    [Abstract] [Full Text] [Related]

  • 37. Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study.
    Almomani BA, Hayajneh WA, Ayoub AM, Ababneh MA, Al Momani MA.
    Infection; 2018 Aug 01; 46(4):495-501. PubMed ID: 29748840
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.